Clinical Trial Update: Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions [NA]

View source ↗

Summary

Clinical trial update reporting the completion of a bioequivalence study of metformin HCl 750 mg extended-release tablets under non-fasting conditions in health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin HCl extended-release 750 mg tablets (metformin hydrochloride, extended-release)

Snippet

Sponsor: Ranbaxy Laboratories Limited | Conditions: Healthy | NA | Status: COMPLETED